VEGFA and renal cell carcinoma: Inactivation of VHL leads to activation of VEGF and PDGF and targets the downstream glutamine transporter SLC1A5, promoting metabolic reprogramming of VHL-deficient RCC and selectively reducing the growth of VHL-deficient RCC [227].